Leukemia and Lymphoma Society: Academic Clinical Trials Program
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $1,000,000 US over three years.
Disciplines:
- Health Sciences
Sponsors:
- Leukemia & Lymphoma Society
Deadlines:
Internal Deadline:
January 23, 2025Sponsor Deadline:
March 20, 2025Additional Dates:
- HRS LOI Due Date - January 23, 2025
- Sponsor LOI Due Date - February 6, 2025
- Sponsor Application Due Date (by invitation) - March 20, 2025
Description:
This opportunity supports investigator-initiated clinical trials that address unmet medical needs in blood cancer. In this program, disease areas of interest include hematologic malignancies and related pre-malignant conditions.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.